DiviTum TKa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DiviTum TKa, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients